journal of international economics
Annals of Internal Medicine
Modern Research in Dentistry|ISSN : 2637-7764
Infection & Drug Resistance
Cancer Management and Research
journal of cellular physiology
Phase III study of trastuzumab emtansine (T-DM1) vs trastuzumab as adjuvant therapy in patients with HER2-positive early breast cancer with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy including trastuzumab: Primary results from KATHERINE.
Journal of Urban Health: